Trends in utilization, mortality, and resource use after implantation of left ventricular assist devices in the United States

被引:8
|
作者
Sanaiha, Yas [1 ]
Downey, Peter [1 ,2 ]
Lyons, Robert [1 ,2 ]
Nsair, Ali [3 ]
Shemin, Richard J. [1 ,2 ]
Benharash, Peyman [1 ,2 ]
机构
[1] Univ Calif Los Angeles, Cardiovasc Outcomes Res Labs CORELAB, Los Angeles, CA USA
[2] Univ Calif Los Angeles, Div Cardiac Surg, Los Angeles, CA USA
[3] Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA
关键词
left ventricular assist device; volume-outcome; trends; resource utilization; mortality; DESTINATION THERAPY; HOSPITAL VOLUME; HEART-FAILURE; OUTCOMES; IMPACT; REGISTRY; SURGEON; COST; CARE;
D O I
10.1016/j.jtcvs.2019.12.121
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Adoption of implantable left ventricular assist devices has dramatically improved survival and quality of life in suitable patients with end-stage heart failure. In the era of value-based healthcare delivery, assessment of clinical outcomes and resource use associated with left ventricular assist devices is warranted. Methods: Adult patients undergoing left ventricular assist device implantation from 2008 to 2016 were identified using the National Inpatient Sample. Hospitals were designated as low-volume, medium-volume, or high-volume institutions based on annual institutional left ventricular assist device case volume. Multivariable logistic regression was used to evaluate adjusted odds of mortality across left ventricular assist device volume tertiles. Results: Over the study period, an estimated 23,972 patients underwent left ven-tricular assist device implantation with an approximately 3-fold increase in the num-ber of annual left ventricular assist device implantations performed (P for trend<.001). In-hospital mortality in patients with left ventricular assist devices decreased from 19.6% in 2008 to 8.1% in 2016 (P for trend<.001) and was higher at low-volume institutions compared with high-volume institutions (12.0% vs 9.2%, P < .001). Although the overall adjusted mortality was higher at low-volume compared with high-volume institutions (adjusted odds ratio, 1.66; 95% confidence interval, 1.28-2.15), this discrepancy was only significant for 2008 and 2009 (low-volume 2008 adjusted odds ratio, 5.5; 95% confidence interval, 1.9-15.8; low-volume 2009 adjusted odds ratio, 2.3; 95% confidence interval, 1.4-3.8). Conclusions: Left ventricular assist device use has rapidly increased in the United States with a concomitant reduction in mortality and morbidity. With maturation of left ventricular assist device technology and increasing experience, volume-related variation in mortality and resource use has diminished. Whether the apparent uni-formity in outcomes is related to patient selection or hospital quality deserves further investigation.
引用
收藏
页码:2083 / 2090
页数:8
相关论文
共 50 条
  • [1] Trends in Utilization, Mortality, Major Complications, and Cost After Left Ventricular Assist Device Implantation in the United States (2009 to 2014)
    Briasoulis, Alexandros
    Inampudi, Chakradhari
    Akintoye, Emmanuel
    Adegbala, Oluwole
    Alvarez, Paulino
    Bhama, Jay
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (10) : 1214 - 1218
  • [2] Outcomes after left ventricular assist device implantation in patients with acute kidney injury
    Silver, Samuel A.
    Long, Jin
    Zheng, Yuanchao
    Goldstone, Andrew B.
    Franz, Doug
    Chang, Tara I.
    Chertow, Glenn M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 159 (02) : 477 - +
  • [3] Racial disparities in in-hospital outcomes after left ventricular assist device implantation
    Ueyama, Hiroki
    Malik, Aaqib
    Kuno, Toshiki
    Yokoyama, Yujiro
    Briasouli, Artemis
    Shetty, Suchith
    Briasoulis, Alexandros
    JOURNAL OF CARDIAC SURGERY, 2020, 35 (10) : 2633 - 2639
  • [4] Postoperative atrial fibrillation is associated with increased morbidity and resource utilization after left ventricular assist device placement
    Hawkins, Robert B.
    Mehaffey, J. Hunter
    Guo, Abra
    Charles, Eric J.
    Speir, Alan M.
    Rich, Jeffrey B.
    Quader, Mohammed A.
    Ailawadi, Gorav
    Yarboro, Leora T.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 156 (04) : 1543 - +
  • [5] United States Trends in Pediatric Ventricular Assist Implantation as Bridge to Transplantation
    Villa, Chet R.
    Khan, Muhammad S.
    Zafar, Farhan
    Morales, David L. S.
    Lorts, Angela
    ASAIO JOURNAL, 2017, 63 (04) : 470 - 475
  • [6] Ventricular Arrhythmias and Mortality After Left Ventricular Assist Devices Implantation: A Meta-Analysis
    Makki, Nader
    Mesubi, Olurotimi
    Steyers, Curtis
    Olshansky, Brian
    CIRCULATION, 2014, 130
  • [7] Mortality in status 2 patients listed for heart transplantation in the United States: Will understanding cause of death help justify implantation of left ventricular assist devices into less sick patients?
    Morris, Alanna A.
    Chen, Christopher
    Laskar, S. Raja
    Smith, Andrew L.
    Vega, J. David
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 276 : 185 - 190
  • [8] Regional Variation in Mortality, Major Complications, and Cost After Left Ventricular Assist Device Implantation in the United States (2009 to 2014)
    Briasoulis, Alexandros
    Inampudi, Chakradhari
    Akintoye, Emmanuel
    Adegbala, Oluwole
    Asleh, Rabea
    Alvarez, Paulino
    Bhama, Jay
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (12) : 1575 - 1580
  • [9] Resource Utilization in Pediatric Patients Supported With Ventricular Assist Devices in the United States: A Multicenter Study From the Pediatric Interagency Registry for Mechanically Assisted Circulatory Support and the Pediatric Health Information System
    Rossano, Joseph W.
    Cantor, Ryan S.
    Dai, Dingwei
    Shamszad, Pirouz
    Huang, Yuan-Shung
    Hall, Matthew
    Lin, Kimberly Y.
    Edens, R. Erik
    Parrino, P. Eugene
    Kirklin, James K.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (11):
  • [10] Independent risk factors for ICU mortality after left ventricular assist device implantation
    Piffard, Marianne
    Nubret-Le Coniat, Karine
    Simon, Olivier
    Leuillet, Sebastien
    Remy, Alain
    Barandon, Laurent
    Ouattara, Alexandre
    ARTIFICIAL ORGANS, 2020, 44 (02) : 153 - 161